Natco Pharma Limited was originally incorporated on 19 September 1981 as private limited company under the name of Natco Fine Pharmaceuticals Private Limited. It became a deemed public company ...

Most stocks in the Nifty Pharma index were in the green, except Natco Pharma. US president Donald is always in the limelight for various reasons and developments. In the latest development ...

Indian pharma stocks fell 1.6% on Monday (May 12, 2025), bucking broader market gains, after U.S. President Donald Trump said he would cut drug prices by 30%–80% to match other wealthy nations.

At close, the index was mildly higher, up 0.15 percent to quote 21,102.70. Constituents such as Mankind Pharma, Natco Pharma and Granules India were the top gainers, rising up to 4.8 percent.

President Donald Trump took on Big Pharma Monday with an executive order that will reduce the prices for prescriptions. The president said the U.S. “will no longer tolerate profiteering and ...

We need more of that,” Kandunoori noted while thanking BCCI President Roger Binny and Rajeev Nannappaneni, CEO of Natco Pharma for helping to keep the mission alive. He was in Bengaluru recently ...

Pharma investors didn’t seem to care. The XBI, a closely tracked index of biotech stocks, was up over 4% by midday, while shares of large pharma companies also rose. Despite concerns that a so ...

May 12 (Reuters) - Indian pharma stocks (.NIPHARM), opens new tab fell 1.6% on Monday, bucking broader market gains, after U.S. President Trump said he would cut drug prices by 30%–80% to match ...

The Nifty Pharma index was the only sectoral index that opened in the red, amid an across-the-board rally. Pharma stocks, however, recovered lost ground, and the Nifty Pharma closed marginally ...

Matthew Herper covers medical innovation — both its promise and its perils. In rolling out his plan to lower prescription drug prices, President Trump could have walked softly and carried a big ...

Shares of global pharma stocks slumped on Monday after President Trump vowed to cut drug prices for Americans by as much as 80%. Novo Nordisk, which generates around 60% of its sales in the U.S ...

Shares rose over 3% following brokerage upgrade Motilal Oswal changed rating to Buy with ₹1,360 target Stock down 25% from recent high of ₹1,592 Shares of Aurobindo Pharma rose over 3% on ...